BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 16543784)

  • 21. Risk factors and medical management of vasospasm after subarachnoid hemorrhage.
    Lazaridis C; Naval N
    Neurosurg Clin N Am; 2010 Apr; 21(2):353-64. PubMed ID: 20380975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
    Romero Kräuchi O; Verger Bennasar AM
    Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
    Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
    Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
    Heffren J; McIntosh AM; Reiter PD
    Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review.
    Wu CT; Wong CS; Yeh CC; Borel CO
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):215-22. PubMed ID: 15679131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aneurysmal subarachnoid hemorrhage: an overview for the practicing neurologist.
    Dupont SA; Wijdicks EF; Lanzino G; Rabinstein AA
    Semin Neurol; 2010 Nov; 30(5):545-54. PubMed ID: 21207347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel treatments for vasospasm after subarachnoid hemorrhage.
    Muroi C; Seule M; Mishima K; Keller E
    Curr Opin Crit Care; 2012 Apr; 18(2):119-26. PubMed ID: 22234053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage].
    Raabe A; Beck J; Berkefeld J; Deinsberger W; Meixensberger J; Schmiedek P; Seifert V; Steinmetz H; Unterberg A; Vajkoczy P; Werner C;
    Zentralbl Neurochir; 2005 May; 66(2):79-91. PubMed ID: 15846536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurologic complications of subarachnoid hemorrhage due to intracranial aneurysm rupture].
    Rama-Maceiras P; Fàbregas Julià N; Ingelmo Ingelmo I; Hernández-Palazón J;
    Rev Esp Anestesiol Reanim; 2010 Dec; 57 Suppl 2():S44-62. PubMed ID: 21298909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers and vasospasm after aneurysmal subarachnoid hemorrhage.
    Jordan JD; Nyquist P
    Neurosurg Clin N Am; 2010 Apr; 21(2):381-91. PubMed ID: 20380977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture.
    Dorsch N
    Acta Neurochir Suppl; 2011; 110(Pt 1):5-6. PubMed ID: 21116906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?
    Zemke D; Farooq MU; Mohammed Yahia A; Majid A
    Vasc Med; 2007 Aug; 12(3):243-9. PubMed ID: 17848485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral vasospasm.
    Weir B; MacDonald L
    Clin Neurosurg; 1993; 40():40-55. PubMed ID: 8111992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral vasospasm and health-related quality of life after subarachnoid hemorrhage.
    Tjahjadi M; König R; Wirtz CR; Woischneck D; Kapapa T
    World Neurosurg; 2013; 80(1-2):113-20. PubMed ID: 23022640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endovascular treatment of vasospasm following subarachnoid aneurysmal haemorrhage].
    Abdennour L; Lejean L; Bonneville F; Boch AL; Puybasset L
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):985-9. PubMed ID: 17935940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia.
    Vergouwen MD; Vermeulen M; Coert BA; Stroes ES; Roos YB
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1761-70. PubMed ID: 18628782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium antagonists in the management of subarachnoid haemorrhage.
    Robinson MJ; Teasdale GM
    Cerebrovasc Brain Metab Rev; 1990; 2(3):205-26. PubMed ID: 2223432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.
    Kramer AH; Gurka MJ; Nathan B; Dumont AS; Kassell NF; Bleck TP
    Neurosurgery; 2008 Feb; 62(2):422-7; discussion 427-30. PubMed ID: 18382320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New therapeutic approaches to subarachnoid hemorrhage.
    Barry C; Turner RJ; Corrigan F; Vink R
    Expert Opin Investig Drugs; 2012 Jun; 21(6):845-59. PubMed ID: 22530758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of multislice computed tomographic angiography for detection of cerebral vasospasm in acute subarachnoid hemorrhage.
    Joo SP; Kim TS; Kim YS; Moon KS; Lee JK; Kim JH; Kim SH
    Minim Invasive Neurosurg; 2006 Oct; 49(5):286-90. PubMed ID: 17163342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.